title: Effects of high-volume, rapid-fluid therapy on cardiovascular function and hematological values during isoflurane-induced hypotension in healthy dogs.
abstract: The objective of this study was to determine the effects of the administration of a high volume of isotonic crystalloid at a rapid rate on cardiovascular function in normovolemic, isoflurane-anesthetized dogs during induced hypotension.Using a prospective study, 6 adult dogs were induced to general anesthesia and cardiovascular and hematological values were measured while the dogs were maintained at 3 hemodynamic states: first during light anesthesia with 1.3% end-tidal isoflurane (ETI); then during a hypotensive state induced by deep anesthesia with 3% ETI for 45 min while administered 1 mL/kg body weight (BW) per minute of isotonic fluids; and then decreased to 1.6% ETI while receiving 1 mL/kg BW per minute of fluids for 15 min. End-tidal isoflurane (ETI) at 3.0 ± 0.2% decreased arterial blood pressure (ABP), cardiac index (CI), and stroke volume index (SVI), and increased stroke volume variation (SVV) and central venous pressure (CVP). Fluid administration during 3% ETI decreased only SVV and systemic vascular resistance index (SVRI), while CVP increased progressively. Decreasing ETI to 1.6 ± 0.1% returned ABP and SVI to baseline (ETI 1.3 ± 0.1%), while CI and heart rate increased and SVV decreased. There was significant progressive clinical hemodilution of hemoglobin (Hb), packed cell volume (PCV), total protein (TP), colloid osmotic pressure (COP), arterial oxygen content (CaO(2)), and central-venous oxygen content (CcvO(2)).High-volume, rapid-rate administration of an isotonic crystalloid was ineffective in counteracting isoflurane-induced hypotension in normovolemic dogs at a deep plane of anesthesia. Cardiovascular function improved only when anesthetic depth was reduced. Excessive hemodilution and its adverse consequences should be considered when a high volume of crystalloid is administered at a rapid rate.
authors.affiliation: Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Ontario, Canada N1G 2W1. valverde@uoguelph.ca
authors.forename: Alexander
authors.initials: A
authors.lastname: Valverde
authors.forename: Giacomo
authors.initials: G
authors.lastname: Gianotti
authors.forename: Eva
authors.initials: E
authors.lastname: Rioja-Garcia
authors.forename: Amanda
authors.initials: A
authors.lastname: Hathway
mesh_terms: D018685:Anesthetics, Inhalation / Q000008:administration & dosage*; D000818:Animals; D001794:Blood Pressure / Q000502:physiology; D002302:Cardiac Output / Q000502:physiology; D000077324:Crystalloid Solutions; D004285:Dogs / Q000502:physiology*; D005260:Female; D005440:Fluid Therapy / Q000662:veterinary*; D006339:Heart Rate / Q000502:physiology; D006400:Hematocrit / Q000662:veterinary; D006454:Hemoglobins / Q000378:metabolism; D007022:Hypotension / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology / Q000662:veterinary*; D007530:Isoflurane / Q000008:administration & dosage*; D007552:Isotonic Solutions / Q000008:administration & dosage*; D008297:Male; D009997:Osmotic Pressure / Q000502:physiology; D011446:Prospective Studies
chemical_list: D018685:Anesthetics, Inhalation; D000077324:Crystalloid Solutions; D006454:Hemoglobins; D007552:Isotonic Solutions; D007530:Isoflurane